Articles for tag: Atai Life Sciences, biotech startups, Bitcoin investment, cryptocurrency strategy, financial diversification, inflation hedge, Regulatory Challenges

Market News

Bitcoin’s Potential Role in Navigating Biotech Winter, Says Biopharma Executive

Atai Life Sciences, a biopharmaceutical company listed on NASDAQ, believes cryptocurrencies like Bitcoin could help biotech startups survive the long and costly regulatory approval process. The firm plans to invest $5 million in Bitcoin as a hedge against inflation and diversifying its assets, according to founder Christian Angermayer. As the biotech industry faces financial challenges, ...

DeFi Explained: Simple Guide Green Crypto and Sustainability China’s Stock Market Rally and Outlook The Future of NFTs The Rise of AI in Crypto